Willingdon Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$215K Sell
1,549
-125
-7% -$17.2K 0.05% 113
2019
Q4
$220K Sell
1,674
-20
-1% -$2.32K 0.05% 125
2019
Q3
$189K Buy
1,694
+57
+3% +$6.35K 0.04% 125
2019
Q2
$181K Hold
1,637
0.04% 128
2019
Q1
$212K Sell
1,637
-50
-3% -$6.08K 0.05% 126
2018
Q4
$195K Hold
1,687
0.06% 133
2018
Q3
$181K Buy
1,687
+672
+66% +$67.2K 0.05% 131
2018
Q2
$87K Hold
1,015
0.03% 157
2018
Q1
$79K Sell
1,015
-700
-41% -$56.4K 0.03% 148
2017
Q4
$145K Buy
1,715
+100
+6% +$8.51K 0.05% 119
2017
Q3
$138K Buy
+1,615
New +$132K 0.05% 114

Other funds holding LLY

Willingdon Wealth Management's LLY Position: Q1 2020 in Review

Willingdon Wealth Management reduced its Eli Lilly (LLY) stake by 7.5% in Q1 2020, selling an estimated $17.2K and leaving 1,549 shares worth $215K. The position accounts for 0.05% of the portfolio, ranked #113.

Willingdon Wealth Management first reported a position in LLY in Q3 2017 and has held it in 11 quarters since. The position peaked at $220K in Q4 2019. 1,684 funds tracked by Wall St. Rank hold LLY as of Q1 2020.

  • Willingdon Wealth Management held 1,549 shares of Eli Lilly worth $215K as of Q1 2020.
  • Willingdon Wealth Management sold 125 Eli Lilly shares in Q1 2020, an estimated $17.2K.
  • Eli Lilly made up 0.05% of Willingdon Wealth Management's portfolio in Q1 2020, its #113 holding.
  • Willingdon Wealth Management first reported a position in Eli Lilly in Q3 2017 and has held it in 11 quarters since.
  • Willingdon Wealth Management's Eli Lilly position peaked at $220K in Q4 2019.
  • 1,684 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2020.

Based on Willingdon Wealth Management's 13F filing for Q1 2020, filed 21 Apr 2020.